To identify mechanisms governing nuclear positioning in muscle, we performed an F3 recessive EMS mutagenesis screen using the *apterous*ME-NLS::dsRed transgenic line (*apRed*)^[@R4]^, which expresses dsRed in the nuclei of the 4 lateral transverse (LT) muscles of the *Drosophila* embryo. At the end of embryogenesis, the myonuclei are distributed throughout the muscles ([Fig. 1a, b](#F1){ref-type="fig"}). One mutation resulted in clustered nuclei near the ventral end of each LT muscle. Within each hemi-segment these clusters resembled the Nike trademark so we named the mutant *swoosh (swo)* ([Fig. 1a](#F1){ref-type="fig"}).

Further analysis of *swo* mutant embryos indicated that myoblast specification^[@R5]^, fusion^[@R5]^, muscle elongation^[@R6],[@R7]^, and attachment^[@R7]^ occur normally. The only notable difference in *swo* mutant muscles is a ventral bulge in the cell body that correlates with the cluster of nuclei ([Supplementary Figs. 1,2](#SD2){ref-type="supplementary-material"}). These data suggest that the clustering of nuclei in *swo* mutants is a bona fide nuclear positioning defect.

To examine nuclear movement, we performed *in vivo* time-lapse imaging on *apRed* control and *swo,apRed* mutant embryos ([Fig. 1b](#F1){ref-type="fig"}). In stage 14 *apRed* control embryos (10.5 h after egg laying \[AEL\]), nuclei in the 4 LT muscles group near the ventral end of each growing myotube in the hemi-segment. During stage 15 (11.5 h AEL) after the completion of myoblast fusion and muscle attachment, the nuclei within each myotube begin to separate into distinct dorsal and ventral clusters. These clusters finish their migration during stage 16 (15 h AEL) and each cluster resides at an opposite end of the myotube. Finally, during stage 17 (18 h AEL), the 6--8 nuclei in each LT muscle move from the clusters and evenly distribute throughout each LT muscle. The entire process of nuclear movement spans 7 hours ([Supplemental Movie 1](#SD2){ref-type="supplementary-material"}). Time lapse imaging of *swo,apRed* mutant embryos demonstrated that the nuclei fail to undergo the initial separation into dorsal and ventral clusters during stage 15 and remain clustered at stage 17 indicating that *swo* does not simply cause a delay in myonuclear positioning ([Supplementary Movie 2](#SD2){ref-type="supplementary-material"}). Additionally, the nuclei in every other somatic muscle examined in *swo* mutant embryos also failed to separate ([Supplementary Fig. 1e](#SD2){ref-type="supplementary-material"}).

We determined that the *swo* flies carry a nonsense mutation in *ensconsin (ens)*, a gene encoding a microtubule associated protein (MAP). Expression of HA-tagged Ens specifically in the developing mesoderm and muscle rescued the nuclear positioning phenotype in *swo* embryos, confirming that the mutation in *ens* is responsible for the nuclear positioning defect. RNAi mediated depletion of *ens* solely in the developing mesoderm and muscle recapitulated the phenotype we observed in the *swo* mutant (renamed *ens^swo^*) and known *ens* mutant alleles failed to complement *ens^swo^* ([Supplementary Fig. 1c, 2a](#SD2){ref-type="supplementary-material"}, data not shown). These data indicate that *ens* is required autonomously within muscle for proper myonuclear positioning. We also found that nuclear position was disrupted in *ens^swo^* oocytes ([Supplementary Fig. 3a,b](#SD2){ref-type="supplementary-material"} and ^[@R8]^), but not in *ens^swo^* photoreceptor cells ([Supplementary Fig. 3c](#SD2){ref-type="supplementary-material"}, data not shown)^[@R9]^, indicating that Ens is necessary for some, but not all, nuclear positioning processes in *Drosophila*.

Four different genes in the mouse genome encode Ens orthologs: *Map7 (E-MAP-115, Ensconsin), Map7D1, Map7D2 and Map7D3* ([Supplementary Fig. 2c](#SD2){ref-type="supplementary-material"}). Using cultures of C2C12 myoblasts and primary mouse myoblasts, we examined the effect on nuclear positioning in myotubes depleted of each Ens ortholog by siRNA ([Fig. 1](#F1){ref-type="fig"}, [Supplementary Fig. 4](#SD2){ref-type="supplementary-material"}). MAP7 depletion caused a significant increase in the aggregation of nuclei within a myotube but did not affect myoblast fusion or myotube differentiation ([Fig. 1c,d](#F1){ref-type="fig"}, [Supplementary Fig. 4d,e, Supplementary Movies 3--6](#SD2){ref-type="supplementary-material"}). Depletion of MAP7D1, MAP7D2 or MAP7D3 did not affect nuclear positioning ([Supplementary Fig. 4b](#SD2){ref-type="supplementary-material"}). Expression of full length MAP7 in MAP7 depleted myotubes restored nuclear alignment ([Fig. 1d](#F1){ref-type="fig"}, [Supplementary Fig 6h](#SD2){ref-type="supplementary-material"}). Thus, MAP7 is required for nuclear positioning in both *Drosophila* muscles and cultured mammalian myotubes.

No major defects on the microtubule network were observed in *ens^swo^* mutant embryos or MAP7 depleted myotubes ([Supplementary Fig. 2g-h, 6g](#SD2){ref-type="supplementary-material"}). Therefore, to gain mechanistic insight, we conducted a yeast-2-hybrid screen to find Ens binding proteins and identified Kinesin heavy chain (Khc) ([Supplementary Fig. 5](#SD2){ref-type="supplementary-material"}). Both a *kinesin* null mutation (*khc^8^*) and a motor dead mutation (*khc^4^*)^[@R10]^ disrupted myonuclear positioning without affecting muscle elongation and attachment. ([Fig. 2a](#F2){ref-type="fig"}, [Supplementary Fig. 5a](#SD2){ref-type="supplementary-material"}). Likewise, siRNA mediated depletion of the mammalian Khc ortholog Kif5b^[@R11]^ in primary and C2C12 myotubes disrupted nuclear alignment similarly to MAP7 depletion without affecting myotube formation or differentiation ([Fig. 2b, c](#F2){ref-type="fig"}, [Supplementary Fig. 4d-e, 6, Supplementary Movies 7,8](#SD2){ref-type="supplementary-material"}). Expression of full length Kif5b in Kif5b depleted myotubes restored nuclear alignment ([Fig. 2c](#F2){ref-type="fig"}, [Supplementary Fig.6h](#SD2){ref-type="supplementary-material"}). These data indicate that Khc, with a functional motor domain, is required for proper nuclear positioning in both *Drosophila* muscles and cultured mammalian myotubes.

We next examined whether Ens and Khc functionally interact to position myonuclei. Embryos heterozygous for *ens* or *khc* position their myonuclei normally. However, embryos that were doubly heterozygous for *ens^swo^* and *khc* displayed defective nuclear positioning similar to the homozygous *ens* embryos ([Supplementary Fig. 5](#SD2){ref-type="supplementary-material"}). This demonstrates that *ens* and *khc* functionally interact and that the dosage of these genes is important for proper nuclear positioning.

We next tested whether Ens/MAP7 and Khc/Kif5b physically interact. Endogenous Kif5b co-immunoprecipitated with expressed full length GFP-tagged MAP7, independent of microtubules ([Fig. 3a,b](#F3){ref-type="fig"}). Using fragments of MAP7, we mapped the Kif5b interaction to the C-terminal coiled-coil domain of MAP7 (CC2), which was confirmed with the reciprocal co-immunoprecipitation ([Fig. 3 a-c](#F3){ref-type="fig"}). Similarly, fragments of Kif5b were used to identify the C-terminal region (Kif5b-motorless) as the MAP7 interacting domain ([Fig. 3a,d,e](#F3){ref-type="fig"}). Therefore, C-terminal coiled-coil domain of MAP7 interacts with the C-terminal region of Kif5b ([Fig. 3](#F3){ref-type="fig"}).

To test whether the specific interaction identified above between Ens/MAP7 and Khc/Kif5b is required for nuclear positioning, we expressed chimeras consisting of the Kif5b motor domain^[@R12]^ fused to fragments of MAP7 that contained (K-EMTB and K-EMTB-M) or lacked (K-N-term) the microtubule binding domain (EMTB)^[@R13]^ in *Map7* siRNA depleted myotubes ([Fig. 3 a, f, g](#F3){ref-type="fig"}). Expression of chimeras that contained the MAP7 EMTB rescued the alignment of nuclei in MAP7 depleted myotubes, whereas expression of the EMTB domain alone, or a chimera that lacked the MAP7 EMTB (K-N-term) did not ([Fig. 3f,g](#F3){ref-type="fig"}). These results indicate that the function of MAP7 in nuclear positioning is to link Kif5b to microtubules.

To investigate the physiological impact of mispositioned nuclei on muscle function *in vivo*, we examined larval motility^[@R14]^. *ens* mutant larvae move significantly slower than controls ([Fig. 4b](#F4){ref-type="fig"}, [Supplementary Fig. 7d](#SD2){ref-type="supplementary-material"}). Moreover, analysis of the muscle structure in tracked larvae revealed that the myonuclei in *ens^swo^* mutants were 33% closer to one another than in controls ([Fig. 4a, c](#F4){ref-type="fig"}, [Supplementary Fig. 7a, e](#SD2){ref-type="supplementary-material"}). Sarcomere structure^[@R15]^, t-tubules^[@R16]^, neuromuscular junctions^[@R17]^, nuclei number ([Supplementary Fig. 7c, e, f, h, i](#SD2){ref-type="supplementary-material"}) and mitochondrial localization ([Supplementary Fig. 8](#SD2){ref-type="supplementary-material"}) were unchanged in *ens* mutants compared to controls. Importantly, expression of Ens in the mesoderm and muscle during embryonic development or in muscle starting at the L2 larval stage in *ens* mutants rescued the nuclear positioning and motility defects in L3 larvae ([Fig. 4a-c](#F4){ref-type="fig"} and [Supplementary Fig. 7a,d,g](#SD2){ref-type="supplementary-material"}) demonstrating a strong correlation between aberrant myonuclear position and reduced muscle function.

These experiments define, for the first time, a subset of the nuclear behaviors that occur during muscle differentiation and demonstrate conservation across species at both the cellular and molecular levels. We find that Ens/MAP7 and Khc/Kif5b are critical for myonuclear positioning and are not required for fusion and myofiber formation. Moreover these proteins interact genetically and physically, and the physical interaction is necessary for proper nuclear positioning. Furthermore, our results argue that the correct spacing of myonuclei is required for proper muscle function.

Within a myotube, distinct microtubule networks emanate from each myonucleus producing regions of overlapping anti-parallel microtubules^[@R18]--[@R20]^. Furthermore, Ens/MAP7 functions to load Khc/Kif5b onto microtubules^[@R8]^. Therefore, the data presented here suggest a molecular mechanism for nuclear positioning. Adjacent nuclei could be positioned relative to each other by Ens/MAP7 and Khc/Kif5b interacting with and sliding anti-parallel microtubules that have their minus ends anchored to the nuclear envelope, similar to the mechanism by which the Eg5 Kinesin facilitates spindle elongation^[@R21]^ ([Supplementary Fig 10](#SD2){ref-type="supplementary-material"}). This mechanism is distinct from the Kinesin-1 dependent nuclear position in the *C. elegans* hypodermis where Khc is anchored to the nucleus by Kinesin light chain (Klc) and the KASH-domain protein Unc-83, which drive the nucleus unidirectionally on microtubules^[@R22]^. We find that *klc* mutants in *Drosophila* do not exhibit defects in the positioning of nuclei that we describe here. Additionally, over-expression of dn-KASH domain constructs in C2C12 myotubes that remove KASH proteins from the nuclear envelope and disrupt LINC complex ([l]{.ul}inker of [n]{.ul}ucleoskeleton and [c]{.ul}ytoskeleton) function and nuclear anchoring^[@R23],[@R24]^ does not affect nuclear positioning ([Supplementary Figure 9](#SD2){ref-type="supplementary-material"}). Together these data suggest that Kinesin is not directly interacting with the nucleus, and therefore provide evidence for the sliding mechanism.

Patients suffering from various muscle diseases, including centronuclear myopathies, display muscle weakness with mislocalized myonuclei^[@R3]^. However, it remains unclear whether these mispositioned nuclei contribute to muscle weakness or are simply a result of impaired myofiber function^[@R3]^. Our results show that the ability to correctly position myonuclei correlates with better muscle function. Because nuclear misposition is the first observable defect in zygotic *ens* mutant embryos, we hypothesize that this is a cause of the observed muscle weakness. Mispositioned nuclei might lead to the observed muscle weakness due to a disruption in the size and spacing of myonuclear domains throughout the muscle^[@R25]^ or in the distribution of sub-cellular structures whose positioning depends upon correct nuclear spacing. We rescue nuclear position, muscle function, and viability not only by supplying Ens during embryogenesis but also by expressing Ens solely in mature muscles later in larval development. Thus, we propose that correcting nuclear positioning defects in patients with muscle diseases might benefit muscle strength and improve muscle function. The model systems that we present here provide a novel platform to identify additional nuclear positioning genes and assess their function and to screen for potential drugs to alleviate muscle weakness due to disease.

Methods Summary {#S1}
===============

*Drosophila* stocks used included *apME-NLS::dsRed*^4^, *Df(3L)GN34*^26^, *ens^HP36480^* (Bloomington), *ens*^f07121^ (Harvard), *Df-ens^Δ3277^, ens^ΔN^*, *ens^ΔC^* ([@R8]), *khc^8^*, *khc^4^*, *khc^23^* ([@R10]), *klc^8ex94^* ([@R27]), *twi-Gal4*^4^, *alpha-Gal4*, *G7-Gal4*^28^ (from K. Broadie), and *UAS-ens-IR* lines 106207 and 18491 (VDRC). *UAS-ensHA* transgenic flies were generated by BestGene Inc. Mouse cells were transfected with siRNA using lipofectamine RNAiMAX (Invitrogen) or DNA using lipofectamine 2000 (Invitrogen). Primary antibodies used were: rabbit anti-dsRed (Clontech), rat anti-tropomyosin (Abcam), mouse anti-myosin heavy chain (from S. Abmayr), rabbit anti-Zasp (from F. Schöck), chicken anti-βgal (Abcam), mouse anti-α-Tubulin (Sigma), rat anti-Ensconsin (from P. Rørth), guinea pig anti-Krüppel (from J. Reinitz), rabbit anti-Eve (from M. Frasch), mouse anti-βPS Integrin (DSHB), rabbit anti-Vestigial (from S. Carroll), FITC conjugated anti-HRP (Jackson ImmunoResearch), mouse anti-Discs large (DSHB), rabbit anti-ATP synthase^[@R29]^ (from H. Duan), rat anti-DE-Cadherin (DSHB), mouse anti-Chaoptin 24B10 (DSHB), rat anti-Elav (DSHB), Alexa Fluor 488 conjugated wheat germ agglutinin (Invitrogen), MF20 (DSHB), rabbit anti-KHC (Santa Cruz), mouse anti-c-Myc (Roche), rabbit anti-GFP (Invitrogen). Secondary antibodies were either biotinylated (Vector Laboratories and Jackson ImmunoResearch) or conjugated to Alexa Fluor 488, 555, or 647. The fusion index^[@R30]^, sarcomere length^[@R15]^, bouton number^[@R17]^, and larval velocity^[@R14]^ were quantified as described with minor modifications (see methods). The yeast 2-hybrid was performed with full length Ens by Hybrigenics S.A Services using a 0--24 hour *Drosophila* cDNA library. Standard protocols were used for immunoprecipitation, western blot, and qPCR experiments and are described in Methods.

METHODS {#S2}
=======

Flies and husbandry {#S3}
-------------------

Stocks were grown and maintained under standard conditions on standard cornmeal medium. Crosses were performed at 25°C. *Drosophila* stocks: *apME-NLS::dsRed*^4^, *Df(3L)GN34*^26^, *ens^HP36480^* (Bloomington), *ens*^f07121^ (Harvard), *ens^ΔN^*, *ens^ΔC^*, *Df-ens^Δ3277^* ([@R8]), *UAS-ensHA* (this study), *khc^8^*, *khc^4^*, *khc^23^* ([@R10]), *klc^8ex94^* ([@R27]), and *UAS-ens-IR* lines 106207 and 18491 (VDRC). Mutant alleles were balanced and identified using *CyO P\[w+en11lacZ\]* or *CTG \[CyO, twi-GAL4, UAS-2xeGFP\]*^[@R26]^*, TM3 Sb1Dfd-lacZ or TTG \[TM3, twi-GAL4, UAS-2xeGFP\]*^[@R31]^. Gal4 lines used in this work were *twi-Gal4*^[@R4]^ that is specifically expressed in the mesoderm and developing muscle (2.5 h AEL to 13 h AEL), and *alpha-Gal4*, *G7-Gal4*^[@R28]^ (gift of K. Broadie) that are specifically expressed in the larval muscles beginning at the late L1 & early L2 larval stages and perdures until pupation.

EMS mutagenesis and screening {#S4}
-----------------------------

A detailed description of the screen and its findings will be described elsewhere. Briefly, males from an isogenized stock carrying the *apME-NLS::dsRed* transgene on the third chromosome were mutagenized with 35mM EMS dissolved in 1% sucrose according to standard protocol^[@R32]^. Individual mutant lines were established over the TTG balancer. Live F3 progeny were screened under fluorescence, and embryos homozygous for the mutant chromosome were identified by an absence of the balancer GFP. Deficiency mapping, complementation, and sequencing were used to identify the genetic lesion.

Phylogenetic analysis {#S5}
---------------------

*Drosophila*, human and mouse MAP7 orthologs were aligned using LALIGN (<http://www.ch.embnet.org/software/LALIGN_form.html>) and the phylogenetic tree was created using Vector NTI (Invitrogen).

Cell culture {#S6}
------------

C2C12 myoblasts were grown and differentiated for 4 days as described^[@R33]^. Primary myoblasts were isolated and differentiated for 3 days as described^[@R30],[@R34]^.

Constructs {#S7}
----------

*Map7* fragments were cloned from a C2C12 cDNA library into pEGFP-C1 vector (Invitrogen) using the following primers: *N-term* (1--2 44): forward 5'-ATGGCGGAGCAGGGAGC-3', reverse 5'-CTAGCTGTTTTTCTCGTTCCTC-3';*EMTB-M* (261--1351): forward 5'-ATGTGGCTAGAGAGAGAAGAACGAG-3', reverse 5'-TAGGAACTACACCGACAGTCACAG-3';*M-CC2-Cterm* (859--2187): forward 5'-ATGACCATTCATGGACTAGCGAG-3', reverse 5'-AACTTCTGCGGTCTGTTGT-3';*M-CC2* (859--1806): forward 5'-ATGACCATTCATGGACTAGCGAG-3', reverse 5'-TTTCTTATCAGCGGTCTCTGTCCTC-3';*CC2-Cterm* (1337--2187):forward 5'-ATGGGCGGTGTAGTTCCTAAGACTTCTG-3', reverse 5'-AACTTCTGCGGTCTGTTGTG-3';*CC2* (1337--1806): forward 5'-ATGGGCGGTGTAGTTCCTAAGACTTCTG-3', reverse 5'-TTTCTTATCAGCGGTCTCTGTCCTC-3';*M* (859--1351): forward 5'-ATGACCATTCATGGACTAGCGAG-3', reverse 5'-TAGGAACTACACCGACAGTCACAG-3'.

Full length *Map7* (NM_008635) was made from the *Map7* fragments and was cloned into pEGFP-C1. *EMTB-Map7* was made by cloning the 1--947 bp fragment from full length *Map7* into the pEGFP-C1 vector. *K-N-term*, *K-EMTB* and *K-EMTB-M* chimera constructs were made by cloning the *K560* fragment from pET17b-K560-GFP (gift from Ron Vale) into *N-Term, EMTB* and *EMTB-M Map7* pEGFP constructs, respectively. *Motor-Kif5b, S-Motorless-Kif5b and Motorless-Kif5b* c-Myc were a gift from Geri Kreitzer. FL-Kif5b was made by cloning the K560 fragment with a C-terminal region of full length Kif5b (gift from Casper C. Hoogenraad) into pEGFP C1 construct. EGFP-KASH2 and EGFP-KASH2ext were a gift from Didier Hodzic^[@R35]^.

siRNA sequences (AMBION): *Map7*: \#118: 5\'-CAGAUUAGAUGUCACCAAUTT-3\', \#119: 5\'-CCAUGAAUCUUUCGAAACATT-3\',\#120: 5\'-ACUUACCUGUUGGAUCAAATT-3\';*Map7*D1: \#710: 5\'-GGAACAGAGGGAACGCGAATT-3\', \#711:5\'-ACGUGGACUCUAUAAUCAATT-3\'.\#712: 5\'-GCAAUCCAGCGGUCAGUGATT-3\';*Map7D2*: \#436: 5\'-CUUUCAACAUCAACCAUGATT-3\', \#437: 5\'-CUUGAUGACUGUAACAAAATT-3\',\#438: 5\'-GGUCUCCUGUGAAGUAUUATT-3\';*Map7D3*: \#000: 5\'-GGACGACAUCUCUAAAGUUTT-3\', \#001: 5\'-GAACUAUCCUCCAUAGUGATT-3\',\#002: 5\'-CUGAUGAGGUUGAUACCAATT-3\',*Kif5b*:, \#781: 5'-GCAAGAAGUAGACCGGAUATT-3', \#782: 5'-GCUGUUAAUUAUGAUCAGATT-3',\#783:5'-GACAUGUCGCAGUUACAAATT-3'

Transfections {#S8}
-------------

Myoblasts were transfected with siRNA using lipofectamine RNAiMAX (Invitrogen) or DNA using lipofectamine 2000 (Invitrogen). H1B-GFP stable cell line was made by transfecting cells with H1B-GFP (gift from Richard Vallee).

qPCR {#S9}
----

mRNA from C2C12 cells was isolated using the RNeasy Micro Kit (QIAGEN) and cDNA was prepared using the Transcriptor 1st strand cDNA synthesis kit (Roche). Quantitative analyses (qPCR) was performed using CyberGreen kit in a LightCycler 480 II system (Roche), using the following primers: *Kif5b-*F, 5'-GGAGGCAAGCAGTCGTAAAC-3;*Kif5b*-R, 5'-TCTAGTGTTGGGAAGCAGCA-3';*Map7*-F, 5'-TGAAACCAATTTTGGCCTTT-3';*Map7*-R, 5'-AAAACCAGAGGGAGGAGCTG-3';*Hprt1*-F, 5'-GTTAAGCAGTACAGCCCCAAA-3';*Hprt1*-R, 5'-AGGGCATATCCAACAACAAACTT-3'.

Immunoprecipitations {#S10}
--------------------

C2C12 cells were transfected with GFP or c-Myc tagged constructs. After 24 hours, cell lysates were prepared using lysis buffer (10 mM Tris, 150 mM NaCl, 0.5mM EDTA, 0.5% NP40, 1mM PMSF, pH 7.4) containing protease inhibitor cocktail (Roche) and 0.6 µM nocodazole (Sigma). Immunoprecipitation of GFP-fusion proteins or endogenous Kif5b were performed at 4°C using the magnetic GFP-Trap kit (Chromotek) or protein A Magnetic Beads (Millipore) coated with Khc antibody, respectively.

Western blot {#S11}
------------

Extracts were loaded on a 4--12% gradient gel (Invitrogen) and transferred using iBlot (Invitrogen).

Immunohistochemistry, immunofluorescence, microscopy, and image analysis {#S12}
------------------------------------------------------------------------

Embryos were collected at 25°C on apple juice agar plates and were fixed as described^[@R4]^ except for tubulin staining where the embryos were fixed in equal volumes of 10% Formalin (Sigma) and heptane (Fisher Scientific). Larvae were dissected and fixed in 4% paraformaldedhyde (EMS) in relaxing buffer as previously described^[@R15],[@R36],[@R37]^. Eye discs were dissected from wandering third-instar larvae and fixed in 4% paraformaldedhyde. Ovaries were dissected from. Ovaries from females that were fed fresh yeast for two days were dissected in PBS and fixed in 4% paraformaldedhyde. All fluorescent stainings were mounted in Prolong Gold (Molecular Probes), otherwise embryos were mounted in Araldite.

Mouse cells were fixed using paraformaldehyde 3.7% (Sigma) and permeabilized with 0.5% Triton. All fluorescent stainings were mounted in Fluoromount G (Southern Biotech).

Antibodies were preabsorbed (PA) where noted and used at the specified final dilutions: rabbit anti-dsRed (1:400, Clontech), rat anti-tropomyosin (1:1000, Abcam), mouse anti-myosin heavy chain (1:400, gift from S. Abmayr), rabbit anti-Zasp (1:400, gift from F. Schöck), chicken anti-βgal (1:1000, Abcam), mouse anti-α-Tubulin (1:500, Sigma), rat anti-Ensconsin (1:100, gift from P. Rørth), guinea pig anti-Krüppel (PA, 1:2000, gift from J. Reinitz), rabbit anti-Eve (PA, 1:3000, gift from M. Frasch), mouse anti-βPS Integrin (1:50, DSHB), rabbit anti-Vestigial (PA, 1:50, gift from S. Carroll), FITC conjugated anti-HRP (1:500, Jackson ImmunoResearch), mouse anti-Discs large (1:200, DSHB), rabbit anti-ATP synthase (1:100, gift from H. Duan)(REF- Pena & Garesse), rat anti-DE-Cadherin (1:100, DSHB), mouse anti-Chaoptin 24B10 (1:200, DSHB), rat anti-Elav (1:50, DSHB), mouse anti-Myosin Heavy Chain MF20 (1:500, DSHB), rabbit anti-KHC (1:2500, Santa Cruz), mouse anti-c-Myc (1:5000, Roche), rabbit anti-GFP (1:2500, Invitrogen). Biotinylated secondary antibodies (Vector Laboratories and Jackson ImmunoResearch) and the Vectastain ABC kit (Vector Laboratories) were applied for non-fluorescent stainings. Alexa Fluor 488-, Alexa Fluor 555-, and Alexa Fluor 647-conjugated secondary antibodies, Alexa Fluor 546-, and Alexa Fluor 647-conjugated phalloidin, Alexa Fluor 488 conjugated wheat germ agglutinin (Invitrogen), and Hoechst 33342 or DAPI were used for fluorescent staining (Invitrogen).

Fluorescent images of *Drosophila* were acquired on a Leica SP5 laser scanning confocal microscope running the LAS AF 2.2 software (objectives used: 20x 0.70 NA HC PL APO multi-immersion, 40x 1.25 NA, 63x 1.4 NA, or 100x 1.43 NA HCX PL APO oil). Non-fluorescent images were acquired on a Zeiss Axiophot microscope. Image stacks were analyzed and processed using Volocity (Improvision), ImageJ, and Photoshop CS4 (Adobe).

Fluorescent images of mouse cells were acquired using a Nikon Ti microscope equipped with a CoolSNAP HQ2 camera (Roper Scientific), an XY motorized stage (Nikon), and a 40x 1.0 NA PL APO oil objective using Metamorph Software (Molecular Devices).

Quantification methods {#S13}
----------------------

Nuclear positioning was quantified in mammalian myotubes containing ≥3 nuclei, and myotubes were classified as follows: "aligned", \> 70% of the nuclei in a myotube align along the same axis; "aggregated", \>70% of the nuclei do not align along the same axis; "other", nuclei in a myotube do not fall into either category. Fusion index was quantified as described^[@R30]^.

A nearest neighbor analysis in *Drosophila* was conducted to determine the average distance between a nucleus and its single closest neighbor within a muscle. To identify the closest neighbor for each nucleus in a muscle, the distance between the center of a nucleus and the center of each of the closely surrounding nuclei (usually 4 -- 8) was measured. The shortest distance identified the closest nucleus or "nearest neighbor" and this distance was recorded. A nearest neighbor was identified for each nucleus in every muscle analyzed and the nearest neighbor distances were averaged to give an average "nearest neighbor" distance for the average space between one nucleus and the next closest nucleus in a muscle.

Sarcomere length was defined as the distance between the Z-lines labeled with the Anti-Zasp antibody^[@R15]^. Sarcomere length was measured at 5 separate regions per muscle and in the same 5 regions for each muscle examined.

Neuromuscular junctions were visualized by HRP or Dlg staining and quantified as previously described^[@R17]^.

The position of the oocyte nucleus was determined by measuring the distance from the anterior border of the oocyte to the center of the nucleus.

Time lapse imaging {#S14}
------------------

*Drosophila* embryos were prepared as described^[@R4],[@R38]^. Time-lapse sequences were acquired using a Zeiss Axio Imager.Z1 with a 20X NA 0.75 Plan-Apochromat dry objective. All time-lapse series were taken as a set of *z*-stacks over time (4D imaging) with optical sections every 3 µm. Only a single z-section with the greatest number of nuclei in focus was selected for each time point. Images were processed using ImageJ and compiled into movie using Apple Quicktime. Single images of live embryos were acquired on a Zeiss Axiophot microscope.

Time lapse imaging of mouse cells was done as reported^[@R30]^.

Yeast 2-hybrid {#S15}
--------------

The yeast two-hybrid screening was based on a full length Ens as bait and performed by Hybrigenics S.A Services using a 0--24 hour embryonic *Drosophila* cDNA library. 99 million interactions were analyzed. 10% of the high confidence clones that were recovered from the screen were Khc.

Larval behavior {#S16}
---------------

Larval behavior was assessed as previously described with minor modifications^[@R14],[@R39]^. Briefly, embryos (stage 16 and 17) were selected for the presence of clustered *apRed* nuclei and/or the absence of the fluorescent balancer. Selected embryos were placed on a yeast-coated apple juice plated overnight at 25°C, and L1 larvae were selected the following day and placed into vials of standard food containing bromophenol blue. Larvae were picked from the vial 3 days later and tracked. Larvae were tracked individually as they migrated towards a single odor source (0.25M ethyl butyrate, Sigma) and recorded with a CCD camera for 5 minutes, until they reached odor source, or until they contacted any of the walls of the apparatus. Images were processed by Ethovision software (Noldus).

Germline transformation and constructs {#S17}
--------------------------------------

*UAS-ensHA* DNA was constructed by PCR amplifying the full length cDNA from the *ens* RA transcript with primers to add an HA tag to the C-terminal end of the protein followed by an EcoR1 restriction site. Primers used were: 5': GCCGAATTCCACCATGGCGAGTCTTGGGGGC, 3':GCCGAATTCTTATCAAGCGTAATCTGGAACATCGTATGGGTACAGCAGCGATATATCTTTATTTTCGTG. Amplified cDNA was introduced into the Uni-ZAP XR vector (a derivative of pBlueScript SK-, Stratagene) using EcoRI/XhoI. This DNA was used by BestGene Inc. to generate transgenic flies.

Statistics {#S18}
----------

Statistical analysis was performed using Prism (GraphPad Software Inc.). Pairwise comparisons were made using a Student's *t* test, and group comparisons were made by ANOVA followed by Tukey's posthoc analysis. In nuclear positioning analysis in C2C12 cells, student's t tests were performed between scrambled siRNA and experimental condition for each category (aligned, aggregated and other).
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![Myonuclear positioning requires Ensconsin/MAP7\
**a.** Hemi-segments from control and *ens^swo^* embryos at beginning (stage 14) and end (stage 17) of nuclear migration. Muscles, tropomyosin (green), Nuclei, dsRed (red). Bar, 10 µm.\
**b.** Timelapse of nuclear migration in control and *ens^swo^* hemisegment. Bar, 10 µm.\
**c.** Timelapse of nuclear migration in control and *Map7* depleted C2C12-H1B-GFP myotubes. Nuclei, red; Bar, 15 um.\
**d.** Nuclear distribution in C2C12 myotubes that were untreated (control) or treated with indicated siRNA and *Map7* depleted cells expressing full length MAP7 (\#118 + FL-MAP7). Error bars, s.e.m. \*\*\*p \< 0.001, \*\*p \< 0.01, \*p \< 0.05 (scrambled vs. experimental condition).](nihms354002f1){#F1}

![Kinesin is required for myonuclear positioning\
**a.** Single hemi-segments from stage 17 (22h AEL) embryos of indicated genotypes; Bar, 10 µm.\
**b.** Representative immunofluorescence images of control and *Kif5b* depleted C2C12 myotubes differentiated for 4 days and immunostained for MHC (green) and DAPI (red). Bars, 15 µm.\
**c.** Histogram of nuclear distribution in C2C12 myotubes that were untreated (control) or treated with the indicated siRNA or *Kif5b* depleted cells expressing full length Kif5b (\#781 + FL-Kif5b). Error bars, s.e.m. \*\*\*p \< 0.001, \*\*p \< 0.01, \*p \< 0.05 (scrambled vs. experimental condition).](nihms354002f2){#F2}

![Kinesin and Ensconsin/MAP7 interact to regulate nuclear position\
**a.** Kif5b, MAP7 and chimera constructs N-terminally tagged with GFP (MAP7/chimeras) or c-Myc (Kif5b). Numbers indicate amino acids.\
**b.** Western blot with indicated antibodies (right) of GFP-MAP7 (top) immunoprecipitations.\
**c.** Anti-GFP Western blot of Kif5b immunoprecipitations from C2C12s expressing indicated constructs (top). (\*) anti-Kif5b IgG.\
**d.** Anti-c-Myc Western blot from C2C12s expressing Kif5b constructs.\
**e.** Anti-c-Myc Western blot from GFP immunoprecipitations using C2C12s expressing indicated constructs.\
**f.** Nuclear distribution in Map7 depleted C2C12s expressing indicated chimeras. Error bars s.e.m. \*\*p \< 0.01, \*p \< 0.05\
**g.** Map7 depleted C2C12s expressing indicated chimeras. Anti-*GFP* (green), Nuclei, DAPI (red). Bar, 15 µm.](nihms354002f3){#F3}

![Ensconsin/MAP7 is required for intracellular muscle organization and efficient larval locomotion\
**a.** Maximum intensity XY projections of muscle VL3 from segment A3 of L3 larvae from the indicated genotypes stained for actin (red), nuclei (white), and Z-bands (green). Bar, 20 µm.\
**b.** Average velocity of migration for L3 larvae of the indicated genotypes. Each of the indicated Gal4 drivers is expressing *UAS-ensHA* in a homozygous *ens^swo^* mutant background. Error bars, s.e.m. \*\*\*p \< 0.001, \*\*p \< 0.01.\
**c.** Nearest neighbor analysis of nuclei within muscle VL3 from segment A3 from L3 larvae of the indicated genotype. Error bars, s.e.m. \*\*\*p \< 0.001, \*\*p \< 0.01.](nihms354002f4){#F4}
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